Related references
Note: Only part of the references are listed.Mitochondrial association of alpha-synuclein causes oxidative stress
M. S. Parihar et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?
Marie-Francoise Chesselet
EXPERIMENTAL NEUROLOGY (2008)
Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein
Katerina E. Paleologou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson disease
Oleg S. Gorbatyuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro
Douglas B. Howard et al.
VIROLOGY (2008)
Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat
Sharon Reimsnider et al.
MOLECULAR THERAPY (2007)
Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain
Jean-Marc Taymans et al.
HUMAN GENE THERAPY (2007)
Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein
Masaki Wakamatsu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Understanding the molecular causes of Parkinson's disease
A. Wood-Kaczmar et al.
TRENDS IN MOLECULAR MEDICINE (2006)
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Eirene Kontopoulos et al.
HUMAN MOLECULAR GENETICS (2006)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease
Shigeki Arawaka et al.
JOURNAL OF NEUROSCIENCE (2006)
α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
Antony A. Cooper et al.
SCIENCE (2006)
Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins
RL Klein et al.
MOLECULAR THERAPY (2006)
Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or-2 serotypes for widespread gene delivery to the neonatal mouse brain
MLD Broekman et al.
NEUROSCIENCE (2006)
Mechanisms and models of alpha-synuclein-related neurodegeneration
Wolfdieter Springer et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2006)
New recombinant serotypes of AAV vectors
GP Gao et al.
CURRENT GENE THERAPY (2005)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
The E46K mutation in α-synuclein increases amyloid fibril formation
EA Greenbaum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system
C Burger et al.
MOLECULAR THERAPY (2004)
Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation
PT Kotzbauer et al.
EXPERIMENTAL NEUROLOGY (2004)
α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
DW Miller et al.
NEUROLOGY (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Modulation of dopamine transporter function by α-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress
C Wersinger et al.
FASEB JOURNAL (2003)
α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
C Lo Bianco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
α-Synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases
CE Ellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Neurochemical findings in the MPTP model of Parkinson's disease
N Schmidt et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Synucleins are a novel class of substrates for G protein-coupled receptor kinases
AN Pronin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
KA Conway et al.
BIOCHEMISTRY (2000)
Constitutive phosphorylation of the Parkinson's disease associated α-synuclein
M Okochi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)